Evidence map›Paper›PMID 27992880›Full record

ArticleNature chemical biology2017

A fluorescent probe for cysteine depalmitoylation reveals dynamic APT signaling.

Rahul S Kathayat, Pablo D Elvira, Bryan C Dickinson

Abstract read
In one paragraph

Article in Nature chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. S-palmitoylation in ferroptosis: molecular mechanisms, modulators, and interplay with autophagy.Apoptosis : an international journal on programmed cell death · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mechanisms and functions of protein S-acylation.Nature reviews. Molecular cell biology · 2024
    Review
  10. Depalmitoylation and cell physiology: APT1 as a mediator of metabolic signals.American journal of physiology. Cell physiology · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Pathogens (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Inhibitors of DHHC family proteins.Current opinion in chemical biology · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rahul S KathayatDepartment of Chemistry, University of Chicago, Chicago, Illinois, USA.
Pablo D ElviraDepartment of Chemistry, University of Chicago, Chicago, Illinois, USA.
Bryan C DickinsonDepartment of Chemistry, University of Chicago, Chicago, Illinois, USA.

Funding

VIRAL ONCOLOGY CORE FACILITYP30CA014599 · NCI · UNIVERSITY OF CHICAGO · PI CHIEN-MIN KAO · 1985 to 2026
$122.1M
Rapid selection approaches to understand and reprogram proteins and peptidesR35GM119840 · NIGMS · UNIVERSITY OF CHICAGO · PI Bryan Dickinson · 2016 to 2026
$4.8M
NCI NIH HHS P30 CA014599NIGMS NIH HHS R35 GM119840
6 · The paper itself

Abstract

Hundreds of human proteins are modified by reversible palmitoylation of cysteine residues (S-palmitoylation), but the regulation of depalmitoylation is poorly understood. Here, we develop 'depalmitoylation probes' (DPPs), small-molecule fluorophores, to monitor the endogenous activity levels of 'erasers' of S-palmitoylation, acylprotein thioesterases (APTs). Live-cell analysis with DPPs reveals rapid growth-factor-mediated inhibition of the depalmitoylation activity of APTs, exposing a novel regulatory mechanism of dynamic lipid signaling.

Indexed as

Signal TransductionCell SurvivalCysteineFluorescent DyesHumansMolecular StructureThiolester HydrolasesTumor Cells, CulturedCysteineFluorescent DyesThiolester Hydrolases

Identifiers

PMID27992880
PMCPMC5247352

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.